1 Wolff M, Corby P, Klaczany G, Santarpia P, Lavender S, Gittens E, Vandeven M, Cummins D, Sullivan R: In vivo effects of a new dentifrice containing 1.5% arginine and 1450 ppm fluoride on plaque metabolism. J Clin Dent 24 (2013), special issue A, A45–A54
2 Santarpia III RP, Lavender S, Gittins E, Vandeven M, Cummins D, Sullivan R: A 12 week clinical study assessing the clinical effects on plaque metabolism of a dentifrice containing 1.5% arginine, an insoluble calcium compound and 1450 ppm fluoride. Am J Dent 27 (2014), 100-105
3 Cantore R, Petrou I, Lavender S, Santarpia P, Liu Z, Gittens E, Vandeven M, Cummins D, Sullivan R, Utgikar N: In situ clinical eff ects of new dentifrices containing 1.5% arginine and fluoride on enamel de- and remineralization and plaque metabolism. J Clin Dent 24 (2013), special issue A, A32-A44
4 Kraivaphan P, Amornchat C, Triratana T, Mateo LR, Ellwood R, Cummins D, DeVizio W, Zhang YP: Two-year caries clinical study of the efficacy of novel dentifrices containing 1.5% arginine, an incoluble calcium compound and 1,450 ppm fluoride. Caries Res 47 (2013), 582-590
5 Li X, Zhong Y, Jiang X, Hu D, Mateo LR, Morrison BM, Zhan YP: Randomized clinical trial of the efficacy of dentifrices containing 1.5% arginine, an insoluble calcium compound and 1450 ppm fluoride over two years. J Clin Dent 26 (2015), 7–12
